Clinical Trial: A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804056) titled 'A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer' on Aug. 26.

Brief Summary: The goal of this clinical trial is to learn if the drug Alpha1H works to treat low-to-intermediate risk non-muscle-invasive bladder cancer in adults. It will also learn about the safety of drug Alpha1H.

The main questions it aims to answer are:

* Does giving drug Alpha1H before surgery lower the risk of cancer returning or worsening compared to standard care alone?

* Is drug Alpha1H safe and well-tolerated by participant...